10-Q Filing

UNITEDHEALTH GROUP INC CIK: 731766 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0000731766-20-000042`
Period End Date	20200630
Filing Date	20200803
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	unh-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 92 Cash Flow Statement 72 Stockholders Equity 65 Comprehensive Income 48

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	950.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	948.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.33B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.74B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	950.00M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$3.27B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$3.26B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$12.55B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$11.82B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$9.64B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$11.43B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.08B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.42B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.93B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.85B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$42.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$58.92B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$37.21B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$36.78B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.70B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.13B	USD	Point-in-time
Goodwill	`Goodwill`	$67.87B	USD	Point-in-time
Goodwill	`Goodwill`	$65.66B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.55B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.35B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$10.24B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$9.33B	USD	Point-in-time
Total assets	`Assets`	$192.48B	USD	Point-in-time
Total assets	`Assets`	$173.89B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$19.89B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$19.20B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$20.91B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.69B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$19.00B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.42B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.87B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$6.16B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.30B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.62B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$14.60B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.80B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$61.78B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.88B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$36.81B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$39.90B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.99B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.29B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$10.14B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.06B	USD	Point-in-time
Total liabilities	`Liabilities`	$111.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$124.13B	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.73B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.84B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 950 and 948 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 950 and 948 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$7.00M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$388.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$67.78B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$61.18B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.55B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.58B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$2.82B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$2.89B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.86B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$173.89B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$192.48B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$94.68B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$100.03B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$47.16B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$49.39B	USD	1 Quarter
Products	`SalesRevenueProductsNet`	$16.68B	USD	2 Qtrs
Products	`SalesRevenueProductsNet`	$16.43B	USD	2 Qtrs
Products	`SalesRevenueProductsNet`	$8.35B	USD	1 Quarter
Products	`SalesRevenueProductsNet`	$8.25B	USD	1 Quarter
Services	`SalesRevenuesServicesNet`	$9.14B	USD	2 Qtrs
Services	`SalesRevenuesServicesNet`	$4.16B	USD	1 Quarter
Services	`SalesRevenuesServicesNet`	$8.81B	USD	2 Qtrs
Services	`SalesRevenuesServicesNet`	$4.50B	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$582.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$341.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$987.00M	USD	2 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$706.00M	USD	2 Qtrs
Total revenues	`Revenues`	$120.90B	USD	2 Qtrs
Total revenues	`Revenues`	$126.56B	USD	2 Qtrs
Total revenues	`Revenues`	$60.59B	USD	1 Quarter
Total revenues	`Revenues`	$62.14B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$75.68B	USD	2 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$39.18B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$78.12B	USD	2 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$34.68B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$10.00B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$8.41B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$20.02B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$16.93B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$14.98B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.50B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.60B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$15.19B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$717.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$654.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.44B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.29B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$55.85B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$52.90B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$112.32B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$111.33B	USD	2 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$14.24B	USD	2 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$4.74B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$9.24B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$9.58B	USD	2 Qtrs
Interest expense	`InterestExpense`	$430.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$867.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$418.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$818.00M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.81B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$13.37B	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.33B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.76B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.82B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.12B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.21B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$941.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.70B	USD	1 Quarter
Net earnings	`ProfitLoss`	$10.16B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$3.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.94B	USD	2 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$92.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$59.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$142.00M	USD	2 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$182.00M	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$6.76B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.02B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$6.64B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.29B	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.47	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$10.56	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$7.09	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$6.99	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$6.91	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$6.97	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$10.43	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$3.42	USD	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	949.00M	shares	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	954.00M	shares	2 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	949.00M	shares	2 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	950.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	14.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	12.00M	shares	2 Qtrs
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	11.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	16.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	961.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	960.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	970.00M	shares	2 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	964.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	11.00M	shares	2 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	11.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	9.00M	shares	2 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	11.00M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$6.70B	USD	1 Quarter
Net earnings	`ProfitLoss`	$10.16B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$3.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.94B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$717.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$654.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.44B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.29B	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$114.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$195.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$388.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$398.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$127.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-124.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.20B	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$439.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.78B	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.77B	USD	2 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-2.35B	USD	2 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$447.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-33.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.59B	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-429.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-296.00M	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.95B	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.11B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.41B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$7.65B	USD	2 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$3.55B	USD	2 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$2.68B	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$3.44B	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$3.31B	USD	2 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.75B	USD	2 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.95B	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$977.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$920.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-504.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$186.00M	USD	2 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.49B	USD	2 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.88B	USD	2 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$1.69B	USD	2 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$4.50B	USD	2 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.19B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.02B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.88B	USD	2 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$2.21B	USD	2 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$448.00M	USD	2 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$870.00M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.25B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$351.00M	USD	2 Qtrs
Proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$6.92B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.86B	USD	2 Qtrs
Customer funds administered	`IncreaseDecreaseInCustomerDeposits`	$1.44B	USD	2 Qtrs
Customer funds administered	`IncreaseDecreaseInCustomerDeposits`	$1.26B	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-529.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-421.00M	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.02B	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$643.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-143.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$6.00M	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.88B	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.34B	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$22.33B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.74B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.33B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.74B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time

Stockholders Equity 65 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.08	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$2.33	USD	2 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.08	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.98	USD	2 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	1 Quarter
Payments of Ordinary Dividends, Common Stock	`PaymentsOfDividendsCommonStock`	$1.19B	USD	Point-in-time
Payments of Ordinary Dividends, Common Stock	`PaymentsOfDividendsCommonStock`	$1.02B	USD	Point-in-time
Payments of Ordinary Dividends, Common Stock	`PaymentsOfDividendsCommonStock`	$1.88B	USD	2 Qtrs
Payments of Ordinary Dividends, Common Stock	`PaymentsOfDividendsCommonStock`	$2.21B	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.86B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	950.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$6.76B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.02B	USD	2 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$6.64B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.29B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$3.35B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$10.12B	USD	2 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$6.67B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$6.87B	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$485.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$810.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$887.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-972.00M	USD	2 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$161.00M	USD	2 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$105.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$287.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$608.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$391.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$378.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$152.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$144.00M	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$4.50B	USD	2 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	-	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.69B	USD	2 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$1.50B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$1.19B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$1.02B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$1.88B	USD	2 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$2.21B	USD	2 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-43.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-285.00M	USD	2 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-133.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-94.00M	USD	2 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$55.00M	USD	2 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$32.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$50.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$145.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$76.00M	USD	2 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$62.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$33.00M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.86B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	950.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time

Comprehensive Income 48 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$6.70B	USD	1 Quarter
Net earnings	`ProfitLoss`	$10.16B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$3.38B	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.94B	USD	2 Qtrs
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.01B	USD	2 Qtrs
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.12B	USD	1 Quarter
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$493.00M	USD	1 Quarter
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$771.00M	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$113.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$257.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$177.00M	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$232.00M	USD	2 Qtrs
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$594.00M	USD	2 Qtrs
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$781.00M	USD	2 Qtrs
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$380.00M	USD	1 Quarter
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$863.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$1.00M	USD	2 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$29.00M	USD	2 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$5.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$11.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	-	USD	2 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$1.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$3.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$7.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$4.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$22.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$1.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$8.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-45.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.54B	USD	2 Qtrs
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$109.00M	USD	1 Quarter
Total foreign currency translation (losses) gains	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$107.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$485.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$810.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$887.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-972.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.51B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.83B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.19B	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$182.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$142.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$59.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$92.00M	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.78B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$7.65B	USD	2 Qtrs
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$7.45B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$9.05B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.